ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity

[1]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[2]  J. Reis-Filho,et al.  AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients , 2016, npj Breast Cancer.

[3]  R. Bonecchi,et al.  Chemokine regulation of neutrophil function in tumors. , 2016, Cytokine & growth factor reviews.

[4]  R. Bonecchi,et al.  Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response , 2016, Front. Immunol..

[5]  K. E. Visser,et al.  Neutrophils in cancer: neutral no more , 2016, Nature Reviews Cancer.

[6]  A. Mantovani,et al.  Atypical chemokine receptors in cancer: friends or foes? , 2016, Journal of leukocyte biology.

[7]  A. Hidalgo,et al.  Aging: A Temporal Dimension for Neutrophils. , 2016, Trends in immunology.

[8]  J. Faith,et al.  Neutrophil ageing is regulated by the microbiome , 2015, Nature.

[9]  J. Jonkers,et al.  IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis , 2015, Nature.

[10]  E. Passegué,et al.  Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils , 2015, Proceedings of the National Academy of Sciences.

[11]  S. Singhal,et al.  Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. , 2014, The Journal of clinical investigation.

[12]  A. Mantovani,et al.  Atypical chemokine receptor 2: a brake against Kaposi's sarcoma aggressiveness , 2014, Oncoimmunology.

[13]  Meixiao Shen,et al.  Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis , 2014, PloS one.

[14]  A. Mantovani,et al.  ERK-Dependent Downregulation of the Atypical Chemokine Receptor D6 Drives Tumor Aggressiveness in Kaposi Sarcoma , 2014, Cancer Immunology Research.

[15]  A. Luster,et al.  Chemokines and chemokine receptors: positioning cells for host defense and immunity. , 2014, Annual review of immunology.

[16]  S. Weiss,et al.  CXCR2‐mediated tumor‐associated neutrophil recruitment is regulated by IFN‐β , 2014, International journal of cancer.

[17]  Guanghui Wang,et al.  CCX-CKR Expression in Colorectal Cancer and Patient Survival , 2014, The International journal of biological markers.

[18]  N. Mukaida,et al.  Role of macrophage inflammatory protein (MIP)-1α/CCL3 in leukemogenesis , 2014, Molecular & cellular oncology.

[19]  V. Vinson.  Dual-Duty Active Site , 2013, Science Signaling.

[20]  Kevin S. Smith,et al.  Pbx1 restrains myeloid maturation while preserving lymphoid potential in hematopoietic progenitors , 2013, Journal of Cell Science.

[21]  R. Nibbs,et al.  Cell-Autonomous Regulation of Neutrophil Migration by the D6 Chemokine Decoy Receptor , 2013, The Journal of Immunology.

[22]  A. Mantovani,et al.  β-Arrestin–Dependent Activation of the Cofilin Pathway Is Required for the Scavenging Activity of the Atypical Chemokine Receptor D6 , 2013, Science Signaling.

[23]  Paul J Hertzog,et al.  Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape , 2012, Nature Medicine.

[24]  A. Mantovani,et al.  Control of murine Ly6C(high) monocyte traffic and immunosuppressive activities by atypical chemokine receptor D6. , 2012, Blood.

[25]  L. Norton,et al.  Tumor entrained neutrophils inhibit seeding in the premetastatic lung. , 2011, Cancer cell.

[26]  Alberto Mantovani,et al.  Neutrophils in the activation and regulation of innate and adaptive immunity , 2011, Nature Reviews Immunology.

[27]  R. Nibbs,et al.  Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. , 2011, Blood.

[28]  F. Cunha,et al.  Essential role of CCR2 in neutrophil tissue infiltration and multiple organ dysfunction in sepsis. , 2011, American journal of respiratory and critical care medicine.

[29]  R. Proia,et al.  S1P1 receptor directs the release of immature B cells from bone marrow into blood , 2010, The Journal of experimental medicine.

[30]  I. Charo,et al.  CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. , 2010, The Journal of clinical investigation.

[31]  A. Richmond,et al.  Chemokines and chemokine receptors: new insights into cancer-related inflammation. , 2010, Trends in molecular medicine.

[32]  P. Allavena,et al.  The chemokine system in cancer biology and therapy. , 2010, Cytokine & growth factor reviews.

[33]  A. Mantovani,et al.  The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 , 2009, Gut.

[34]  G. Cheng,et al.  Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. , 2009, Cancer cell.

[35]  L. Coussens,et al.  CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. , 2009, Cancer cell.

[36]  F. Baleux,et al.  CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. , 2009, Blood.

[37]  W. Born,et al.  IL‐17‐producing γδ T cells , 2009, European Journal of Immunology.

[38]  T. Mcclanahan,et al.  Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  T. Kuijpers,et al.  Infiltrated Neutrophils Acquire Novel Chemokine Receptor Expression and Chemokine Responsiveness in Chronic Inflammatory Lung Diseases , 2008, The Journal of Immunology.

[40]  Z. Ou,et al.  Chemokine Decoy Receptor D6 Plays a Negative Role in Human Breast Cancer , 2008, Molecular Cancer Research.

[41]  A. Mantovani,et al.  Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation. , 2008, Blood.

[42]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[43]  R. Nibbs,et al.  The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. , 2007, The Journal of clinical investigation.

[44]  Alberto Mantovani,et al.  Tuning inflammation and immunity by chemokine sequestration: decoys and more , 2006, Nature Reviews Immunology.

[45]  Manuela Gariboldi,et al.  Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  F. Balkwill.  Cancer and the chemokine network , 2004, Nature Reviews Cancer.

[47]  S. Saccani,et al.  Regulation of the Chemokine Receptor CXCR4 by Hypoxia , 2003, The Journal of experimental medicine.

[48]  M. Colombo,et al.  Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. , 2003, Blood.

[49]  G. Clayman,et al.  Chemokines in cancer , 2001, Expert Reviews in Molecular Medicine.

[50]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[51]  Piero Musiani,et al.  DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice1 2 , 2000, The Journal of Immunology.

[52]  C. Mackay,et al.  Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils. , 1999, Journal of immunology.

[53]  R. Nibbs,et al.  Cloning and Characterization of a Novel Promiscuous Human β-Chemokine Receptor D6* , 1997, The Journal of Biological Chemistry.

[54]  H. Brühl,et al.  Flow Cytometry Detection of Chemokine Receptors for the Identification of Murine Monocyte and Neutrophil Subsets. , 2016, Methods in enzymology.

[55]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[56]  A. Mantovani,et al.  Chemokine decoy receptors: structure-function and biological properties. , 2010, Current topics in microbiology and immunology.

[57]  W. Kuziel,et al.  Macrophage inflammatory protein-1alpha uses a novel receptor for primitive hemopoietic cell inhibition. , 2001, Blood.